241 filings
Page 7 of 13
8-K
n7984n
28 Oct 19
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results
7:05am
8-K
gtsghwbkjl8d
30 Aug 19
Entry into a Material Definitive Agreement
4:10pm
424B5
32k pe1a4uaa
30 Aug 19
Prospectus supplement for primary offering
4:08pm
S-8
n7bq4 2qla4txlr578wu
29 Jul 19
Registration of securities for employees
4:32pm
8-K
xs7tb ajb2c0b
29 Jul 19
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results
4:05pm
8-K
65r gsgie
26 Jun 19
Other Events
8:45am
8-K
jeu3z4
13 Jun 19
Departure of Directors or Certain Officers
4:44pm
8-K
0glff wdee6xfna8d
6 Jun 19
Entry into a Material Definitive Agreement
5:20pm
DEFA14A
5e582vvm
30 Apr 19
Additional proxy soliciting materials
4:07pm
UPLOAD
rhsbn7uoxl44ysy2ycmx
30 Apr 19
Letter from SEC
12:00am
8-K
hlftsnd1 6387
29 Apr 19
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results
4:05pm
CORRESP
9bwzp4l4vtc11xauf3
29 Apr 19
Correspondence with SEC
12:00am
UPLOAD
q6kbfwb
26 Apr 19
Letter from SEC
12:00am
PRER14A
q8jbz k7my86v
23 Apr 19
Preliminary revised proxy
2:34pm
CORRESP
cxn340kis4prbv4gk8p
23 Apr 19
Correspondence with SEC
12:00am